Search by Drug Name or NDC

    NDC 00407-1415-09 OMNIPAQUE 9 mg/mL Details

    OMNIPAQUE 9 mg/mL

    OMNIPAQUE is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GE Healthcare Inc.. The primary component is IOHEXOL.

    Product Information

    NDC 00407-1415
    Product ID 0407-1415_9b00a600-5fce-4dd5-8db4-26248d46f0d9
    Associated GPIs 94402042002060
    GCN Sequence Number 079351
    GCN Sequence Number Description iohexol SOLUTION 9 MG/ML ORAL
    HIC3 A6U
    HIC3 Description CARDIOVASCULAR DIAGNOSTICS-RADIOPAQUE
    GCN 45842
    HICL Sequence Number 000151
    HICL Sequence Number Description IOHEXOL
    Brand/Generic Brand
    Proprietary Name OMNIPAQUE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Iohexol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 9
    Active Ingredient Units mg/mL
    Substance Name IOHEXOL
    Labeler Name GE Healthcare Inc.
    Pharmaceutical Class Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA018956
    Listing Certified Through 2024-12-31

    Package

    NDC 00407-1415-09 (00407141509)

    NDC Package Code 0407-1415-09
    Billing NDC 00407141509
    Package 10 BOTTLE, PLASTIC in 1 BOX (0407-1415-09) / 500 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2018-04-27
    NDC Exclude Flag N
    Pricing Information N/A